A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain

[1]  E. Masliah,et al.  Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies. , 2009, The American journal of pathology.

[2]  V. Buchman,et al.  γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein , 2009, Human molecular genetics.

[3]  E. Israeli,et al.  β‐Synuclein occurs in vivo in lipid‐associated oligomers and forms hetero‐oligomers with α‐synuclein , 2009, Journal of neurochemistry.

[4]  A. Czurkó,et al.  The mode of death of epilepsy-induced “dark” neurons is neither necrosis nor apoptosis: An electron-microscopic study , 2008, Brain Research.

[5]  Michael T. McManus,et al.  Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration , 2008, Proceedings of the National Academy of Sciences.

[6]  Bernd J. Pichler,et al.  Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease , 2008, The Journal of Neuroscience.

[7]  E. Masliah,et al.  Enhanced Lysosomal Pathology Caused by β-Synuclein Mutants Linked to Dementia with Lewy Bodies* , 2007, Journal of Biological Chemistry.

[8]  C. Griesinger,et al.  Structural characterization of the intrinsically unfolded protein β-synuclein, a natural negative regulator of α-synuclein aggregation , 2007 .

[9]  Makoto Hashimoto,et al.  Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. , 2007, Biochemical and biophysical research communications.

[10]  S. Inoue,et al.  alpha-Synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity. , 2007, The Journal of biological chemistry.

[11]  Andrew D. Steele,et al.  The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases , 2007, Proceedings of the National Academy of Sciences.

[12]  John Q. Trojanowski,et al.  -synuclein modulates -synuclein neurotoxicity by reducing -synuclein protein expression , 2006 .

[13]  C. Brayne,et al.  A systematic review of prevalence and incidence studies of dementia with Lewy bodies. , 2005, Age and ageing.

[14]  E. Masliah,et al.  An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model , 2004, Gene Therapy.

[15]  J. Trojanowski,et al.  β-Synuclein gene alterations in dementia with Lewy bodies , 2004, Neurology.

[16]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[17]  C. Mytilineou,et al.  Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions , 2004, Journal of neurocytology.

[18]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[19]  Suneil K. Kalia,et al.  Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP , 2003, Brain Research.

[20]  Peter T Lansbury,et al.  Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. , 2003, Biochemistry.

[21]  B. Volpe,et al.  Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat , 2003, Neuroscience.

[22]  Matthew P Frosch,et al.  The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease , 2003, Neuron.

[23]  Makoto Hashimoto,et al.  Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters , 2002, Journal of neuroscience research.

[24]  Y. Ouchi,et al.  Differential expression of secreted frizzled-related protein 4 in decidual cells during pregnancy. , 2002, Journal of molecular endocrinology.

[25]  Sebastian Doniach,et al.  Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.

[26]  R. Cole,et al.  Cytosolic O‐glycosylation is abundant in nerve terminals , 2001, Journal of neurochemistry.

[27]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[28]  Makoto Hashimoto,et al.  β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[30]  M. Citron,et al.  Parkinson's Disease-associated α-Synuclein Is More Fibrillogenic than β- and γ-Synuclein and Cannot Cross-seed Its Homologs* , 2000, The Journal of Biological Chemistry.

[31]  J. Trojanowski,et al.  Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .

[32]  S. W. Davies,et al.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J Q Trojanowski,et al.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[35]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[36]  B. Volpe,et al.  Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions , 1998, Neuroscience.

[37]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[38]  M. Delong,et al.  Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.

[39]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[40]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Nakajo,et al.  A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. , 1993, European journal of biochemistry.

[42]  H J Gundersen,et al.  Stereology: the fast lane between neuroanatomy and brain function ‐ or still only a tightrope? , 1992, Acta neurologica Scandinavica. Supplementum.

[43]  Richard E. Coggeshall,et al.  A consideration of neural counting methods , 1992, Trends in Neurosciences.

[44]  H. Kawano,et al.  Substance P-like immunoreactive neurons in the tuberoinfundibular area of rat hypothalamus. Light and electron microscopy , 1983, Brain Research.

[45]  T. Fujita,et al.  Immunocytochemical demonstration of the co-storage of noradrenaline with Met-enkephalin-Arg6-Phe7 and Met-enkephalin-Arg6-Gly7-Leu8 in the carotid body chief cells of the dog. , 1983, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.

[46]  S. Carpenter.  Proximal axonal enlargement in motor neuron disease , 1968, Neurology.

[47]  V. Caviness,et al.  HEMORRHAGES INTO PERIPHERAL NERVES IN ASSOCIATION WITH LEUKEMIA. , 1964 .

[48]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[49]  H. Kawano,et al.  Ontogenetic studies on the topographical heterogeneity of somatostatin-containing neurons in rat hypothalamus , 2004, Cell and Tissue Research.

[50]  Robert Lalonde.  Motor abnormalities in weaver mutant mice , 2004, Experimental Brain Research.

[51]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[52]  A. Członkowska,et al.  Ultrastructural changes in substantia nigra and striatum observed on a mouse model of Parkinson's disease induced by MPTP administration. , 1999, Folia neuropathologica.

[53]  F. Seitelberger,et al.  Neuropathological conditions related to neuroaxonal dystrophy. , 1971, Acta neuropathologica.